303 related articles for article (PubMed ID: 31559140)
1. Granulocytic Myeloid-Derived Suppressor Cells Promote the Stemness of Colorectal Cancer Cells through Exosomal S100A9.
Wang Y; Yin K; Tian J; Xia X; Ma J; Tang X; Xu H; Wang S
Adv Sci (Weinh); 2019 Sep; 6(18):1901278. PubMed ID: 31559140
[TBL] [Abstract][Full Text] [Related]
2. G-MDSC-derived exosomes mediate the differentiation of M-MDSC into M2 macrophages promoting colitis-to-cancer transition.
Wang Y; Liu H; Zhang Z; Bian D; Shao K; Wang S; Ding Y
J Immunother Cancer; 2023 Jun; 11(6):. PubMed ID: 37364932
[TBL] [Abstract][Full Text] [Related]
3. Exosomes derived from myeloid-derived suppressor cells facilitate castration-resistant prostate cancer progression via S100A9/circMID1/miR-506-3p/MID1.
Gao F; Xu Q; Tang Z; Zhang N; Huang Y; Li Z; Dai Y; Yu Q; Zhu J
J Transl Med; 2022 Aug; 20(1):346. PubMed ID: 35918733
[TBL] [Abstract][Full Text] [Related]
4. Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19.
Ren J; Ding L; Zhang D; Shi G; Xu Q; Shen S; Wang Y; Wang T; Hou Y
Theranostics; 2018; 8(14):3932-3948. PubMed ID: 30083271
[TBL] [Abstract][Full Text] [Related]
5. Granulocytic Myeloid-Derived Suppressor Cell Exosomal Prostaglandin E2 Ameliorates Collagen-Induced Arthritis by Enhancing IL-10
Wu X; Zhu D; Tian J; Tang X; Guo H; Ma J; Xu H; Wang S
Front Immunol; 2020; 11():588500. PubMed ID: 33329572
[TBL] [Abstract][Full Text] [Related]
6. S100A9 Regulates MDSCs-Mediated Immune Suppression via the RAGE and TLR4 Signaling Pathways in Colorectal Carcinoma.
Huang M; Wu R; Chen L; Peng Q; Li S; Zhang Y; Zhou L; Duan L
Front Immunol; 2019; 10():2243. PubMed ID: 31620141
[TBL] [Abstract][Full Text] [Related]
7. Exosomal miRNA-166-5p derived from G-MDSCs promotes proliferation by targeting ITM3E in colorectal cancer.
Ma T; Jiang J; Shi M; Xu H
Environ Toxicol; 2024 Feb; 39(2):803-814. PubMed ID: 37792719
[TBL] [Abstract][Full Text] [Related]
8. CAFs shape myeloid-derived suppressor cells to promote stemness of intrahepatic cholangiocarcinoma through 5-lipoxygenase.
Lin Y; Cai Q; Chen Y; Shi T; Liu W; Mao L; Deng B; Ying Z; Gao Y; Luo H; Yang X; Huang X; Shi Y; He R
Hepatology; 2022 Jan; 75(1):28-42. PubMed ID: 34387870
[TBL] [Abstract][Full Text] [Related]
9. Loss of exosomal miR-200b-3p from hypoxia cancer-associated fibroblasts promotes tumorigenesis and reduces sensitivity to 5-Flourouracil in colorectal cancer via upregulation of ZEB1 and E2F3.
Gong W; Guo Y; Yuan H; Chai R; Wan Z; Zheng B; Hu X; Chen B; Gao S; Dai Q; Yu P; Tu S
Cancer Gene Ther; 2023 Jun; 30(6):905-916. PubMed ID: 36890211
[TBL] [Abstract][Full Text] [Related]
10. IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.
Yang Q; Li X; Chen H; Cao Y; Xiao Q; He Y; Wei J; Zhou J
Oncogene; 2017 May; 36(21):2969-2980. PubMed ID: 28092673
[TBL] [Abstract][Full Text] [Related]
11. Gut fungi enhances immunosuppressive function of myeloid-derived suppressor cells by activating PKM2-dependent glycolysis to promote colorectal tumorigenesis.
Zhang Z; Zheng Y; Chen Y; Yin Y; Chen Y; Chen Q; Hou Y; Shen S; Lv M; Wang T
Exp Hematol Oncol; 2022 Nov; 11(1):88. PubMed ID: 36348389
[TBL] [Abstract][Full Text] [Related]
12. CAFs secreted exosomes promote metastasis and chemotherapy resistance by enhancing cell stemness and epithelial-mesenchymal transition in colorectal cancer.
Hu JL; Wang W; Lan XL; Zeng ZC; Liang YS; Yan YR; Song FY; Wang FF; Zhu XH; Liao WJ; Liao WT; Ding YQ; Liang L
Mol Cancer; 2019 May; 18(1):91. PubMed ID: 31064356
[TBL] [Abstract][Full Text] [Related]
13. Hydrogen Sulfide Reduces Myeloid-Derived Suppressor Cell-Mediated Inflammatory Response in a Model of
De Cicco P; Sanders T; Cirino G; Maloy KJ; Ianaro A
Front Immunol; 2018; 9():499. PubMed ID: 29636751
[TBL] [Abstract][Full Text] [Related]
14. Myeloid-Derived Suppressor Cells: A New and Pivotal Player in Colorectal Cancer Progression.
Yin K; Xia X; Rui K; Wang T; Wang S
Front Oncol; 2020; 10():610104. PubMed ID: 33384962
[TBL] [Abstract][Full Text] [Related]
15. Tumor-induced myeloid-derived suppressor cells promote tumor progression through oxidative metabolism in human colorectal cancer.
OuYang LY; Wu XJ; Ye SB; Zhang RX; Li ZL; Liao W; Pan ZZ; Zheng LM; Zhang XS; Wang Z; Li Q; Ma G; Li J
J Transl Med; 2015 Feb; 13():47. PubMed ID: 25638150
[TBL] [Abstract][Full Text] [Related]
16. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
17. Characterization of the perioperative changes of exosomal immune-related cytokines induced by prostatectomy in early-stage prostate cancer patients.
Macías M; García-Cortés Á; Torres M; Ancizu-Marckert J; Ignacio Pascual J; Díez-Caballero F; Enrique Robles J; Rosell D; Miñana B; Mateos B; Ajona D; Sánchez-Bayona R; Bedialauneta O; Chocarro S; Navarro A; Andueza MP; Gúrpide A; Luis Perez-Gracia J; Alegre E; González Á
Cytokine; 2021 May; 141():155471. PubMed ID: 33607398
[TBL] [Abstract][Full Text] [Related]
18. Induction of myeloid-derived suppressor cells by tumor exosomes.
Xiang X; Poliakov A; Liu C; Liu Y; Deng ZB; Wang J; Cheng Z; Shah SV; Wang GJ; Zhang L; Grizzle WE; Mobley J; Zhang HG
Int J Cancer; 2009 Jun; 124(11):2621-33. PubMed ID: 19235923
[TBL] [Abstract][Full Text] [Related]
19. Glioma exosomes mediate the expansion and function of myeloid-derived suppressor cells through microRNA-29a/Hbp1 and microRNA-92a/Prkar1a pathways.
Guo X; Qiu W; Wang J; Liu Q; Qian M; Wang S; Zhang Z; Gao X; Chen Z; Guo Q; Xu J; Xue H; Li G
Int J Cancer; 2019 Jun; 144(12):3111-3126. PubMed ID: 30536597
[TBL] [Abstract][Full Text] [Related]
20. Exosomes Derived From Dendritic Cells Infected With
Lu J; Wei N; Zhu S; Chen X; Gong H; Mi R; Huang Y; Chen Z; Li G
Front Oncol; 2022; 12():899737. PubMed ID: 35600363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
